OTC:XAGE | Free Cash Flow | Longevity Health Holdings, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2021-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$485,291.00
2025-12-31-$306,367.00$1.00-$306,368.00
2025-03-31-$752,953.00
2024-12-31-$772,063.00
2024-03-31-$1.08M
2023-12-31-$3.41M$0.00-$3.41M-108.04%
2023-03-31-$475,959.00
2022-12-31-$2.3M$3,585.00-$2.3M
2022-03-31-$151,674.00
2021-12-31-$70,926.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$3.33M$14,225.00-$3.34M
2024-12-31-$3.89M
2023-12-31-$8.35M$30,470.00-$8.38M
2022-12-31-$3.43M$7,164.00-$3.44M
2021-12-31-$451,167.00

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.